Evidence map›Paper›PMID 38093559›Full record

ArticleClinical and translational medicine2023

Association of lung diseases with coronavirus disease 2019 in cancer patients receiving immune checkpoint inhibitors: A multicenter study during national Omicron outbreak in China.

Yanlin Li, Tongfei Wang, Yamin Zhang, Miao Li, Xiemin Feng, Rui Xu, Hong Xu, Weihu Xia, Yaning Zhao, Xinli Hou and 20 more

Open access · goldAbstract readMulticenter StudyLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 13 institutions in 2 countries.

Yanlin LiDepartment of Medical Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Tongfei WangDepartment of Medical Oncology, Xi 'an No.3 Hospital, the Affiliated Hospital of Northwest University, Xi'an, China.
Yamin ZhangDepartment of Oncology, Xi'an International Medical Center Hospital, Xi'an, China.
Miao LiDepartment of Medical Oncology, Qinghai Provincial Cancer Hospital, Fifth People's Hospital of Qinghai Province, Xi'an, China.
Xiemin FengDepartment of Medical Oncology, Yan'an University Affiliated Hospital, Yan'an, China.
Rui XuDepartment of Medical Oncology, Shaanxi Provincial Cancer Hospital, Xi'an, China.
Hong XuDepartment of Medical Oncology, Xi 'an No.3 Hospital, the Affiliated Hospital of Northwest University, Xi'an, China.
Weihu XiaDepartment of Oncology, Xi'an International Medical Center Hospital, Xi'an, China.
Yaning ZhaoDepartment of Medical Oncology, Baoji Central Hospital, Baoji, China.
Xinli HouDepartment of Medical Oncology, Hanzhong Central Hospital, Hanzhong, China.
Hui Wei4th Department of Oncology, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, China.
Zhiyan LiuDepartment of Respiratory and Critical Care Medicine, Xi 'an No.3 Hospital, the Affiliated Hospital of Northwest University, Xi'an, China.
Ying ZanDepartment of Medical Oncology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Bing ZhaoDepartment of Pulmonary Medicine, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, China.
Chunling LiuDepartment of Pulmonary Medicine, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, China.
Xiaopeng HeDepartment of Respiratory Medicine, Xianyang Central Hospital, Xianyang, China.
Xuan LiangDepartment of Medical Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Mengjie LiuDepartment of Medical Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Lili JiangDepartment of Medical Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Wenjuan WangDepartment of Medical Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Yuan ShenDepartment of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Duolao WangDepartment of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Baibing MiDepartment of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Yixue BaiDepartment of Medical Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Xin YuDepartment of Medical Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Xubo HuangDepartment of Medical Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Xiaohui JiaDepartment of Medical Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Xiaolan FuDepartment of Medical Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Hui GuoDepartment of Medical Oncology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.ORCID 0000-0001-9780-0845
Min JiaoDepartment of Medical Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
First Affiliated Hospital of Xi'an Jiaotong University · CNNorthwest University · CNXi'an Jiaotong University · CNMedical Center Hospital · USSecond Affiliated Hospital of Xi'an Jiaotong University · CNXinjiang Medical University · CNAffiliated Hospital of Shaanxi University of Chinese Medicine · CNBaoji City Central Hospital · CNHanzhong Central Hospital · CNQinghai Provincial Peoples Hospital · CNShanxi Medical University · CNXian Yang Central Hospital · CNYanan University Affiliated Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Lung NeoplasmsChinaDisease OutbreaksHumansImmune Checkpoint InhibitorsImmune Checkpoint Inhibitors

Identifiers

PMID38093559
PMCPMC10719537
OpenAlexW4389737556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.